Publications

2024

Deep Learning Algorithms for Bladder Cancer Segmentation on Multi-Parametric MRI.

Cancers.16(13):-[DOI] 10.3390/cancers16132348.[PMID] 39001410.

1 citations·PubMed·Publisher's Site

2024

MRI-based radiomic features for identifying recurrent prostate cancer after proton radiation therapy.

Journal of applied clinical medical physics.25(3):e14293-[DOI] 10.1002/acm2.14293.[PMID] 38409947.

1 citations·PubMed·Publisher's Site

2023

Can magnetic resonance imaging differentiate muscle invasion (T2) and lamina propria invasion (T1) urothelial carcinoma of the bladder? A systematic review and meta-analysis of Vesical Imaging-Reporting and Data System accuracy.

Current urology.17(4):262-267[DOI] 10.1097/CU9.0000000000000214.[PMID] 37994331.

1 citations·PubMed·Publisher's Site

2023

Does care fragmentation in patients with bladder cancer lead to worse outcomes?

Urologic oncology.41(3):147.e7-147.e14[DOI] 10.1016/j.urolonc.2022.10.028.[PMID] 36631369.

PubMed·Publisher's Site

2023

Extramural venous invasion: a novel magnetic resonance imaging biomarker for adverse pathology in bladder cancer.

American journal of clinical and experimental urology.11(2):185-193[DOI] .[PMID] 37168940.

PubMed·Publisher's Site

2023

Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.

Urologic oncology.41(3):145.e1-145.e5[DOI] 10.1016/j.urolonc.2022.10.007.[PMID] 36496342.

1 citations·PubMed·Publisher's Site

2023

Natural history, and impact of surgery and radiation on survival outcomes of men diagnosed with low-grade prostate cancer at ≤ 55 years of age: a 25-year follow-up of > 60,000 men.

International urology and nephrology.55(2):295-300[DOI] 10.1007/s11255-022-03363-6.[PMID] 36171482.

5 citations·PubMed·Publisher's Site

2023

The geriatric nutritional risk index predicts complications after nephrectomy for renal cancer.

International braz j urol : official journal of the Brazilian Society of Urology.49(1):97-109[DOI] 10.1590/S1677-5538.IBJU.2022.0380.[PMID] 36512458.

6 citations·PubMed·Publisher's Site

2022

Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis.

Indian journal of urology : IJU : journal of the Urological Society of India.38(3):220-226[DOI] 10.4103/iju.iju_402_21.[PMID] 35983120.

PubMed·Publisher's Site

2022

Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.

Urologic oncology.40(2):45-55[DOI] 10.1016/j.urolonc.2021.11.008.[PMID] 34895996.

11 citations·PubMed·Publisher's Site

2022

Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis.

Abdominal radiology (New York).47(12):4173-4185[DOI] 10.1007/s00261-022-03669-0.[PMID] 36112202.

13 citations·PubMed·Publisher's Site

2022

The Geriatric Nutritional Risk Index Predicts Postoperative Outcomes in Bladder Cancer: A Propensity Score-Matched Analysis.

The Journal of urology.207(4):797-804[DOI] 10.1097/JU.0000000000002342.[PMID] 34854753.

19 citations·PubMed·Publisher's Site

2021

An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.

Journal of endourology.35(4):409-416[DOI] 10.1089/end.2020.0739.[PMID] 32962442.

30 citations·PubMed·Publisher's Site

2021

Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.

Journal of robotic surgery.15(3):321-333[DOI] 10.1007/s11701-020-01174-4.[PMID] 33222043.

17 citations·PubMed·Publisher's Site

2021

MRI and CT bladder segmentation from classical to deep learning based approaches: Current limitations and lessons.

Computers in biology and medicine.134():104472-[DOI] 10.1016/j.compbiomed.2021.104472.[PMID] 34023696.

20 citations·PubMed·Publisher's Site

2021

Pathology grade influences competing mortality risks in elderly men with prostate cancer.

Urologic oncology.39(8):493.e1-493.e7[DOI] 10.1016/j.urolonc.2020.12.004.[PMID] 33353870.

1 citations·PubMed·Publisher's Site

2021

Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?

Radiology.298(1):E57-[DOI] 10.1148/radiol.2020202870.[PMID] 33141006.

3 citations·PubMed·Publisher's Site

2020

A Systematic Review and Meta-Analysis of Methods Used to Reduce Infectious Complications Following Transrectal Prostate Biopsy.

Urology.144():21-27[DOI] 10.1016/j.urology.2020.06.005.[PMID] 32569659.

3 citations·PubMed·Publisher's Site

2020

Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis.

Urologic oncology.38(11):826-834[DOI] 10.1016/j.urolonc.2020.03.022.[PMID] 32605736.

24 citations·PubMed·Publisher's Site

2018

Percutaneous ablative cryoimmunotherapy for micrometastaic abscopal effect: No complications.

Cryobiology.82():22-26[DOI] 10.1016/j.cryobiol.2018.04.013.[PMID] 29680230.

22 citations·PubMed·Publisher's Site

2018

Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement.

American journal of clinical oncology.41(12):1243-1245[DOI] 10.1097/COC.0000000000000454.[PMID] 29727310.

1 citations·PubMed·Publisher's Site

2017

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.

Cancer.123(15):2850-2859[DOI] 10.1002/cncr.30665.[PMID] 28422278.

56 citations·PubMed·Publisher's Site

1990

Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury.

The Journal of urology.143(2):407-13[DOI] .[PMID] 2299741.

76 citations·PubMed·Publisher's Site

Show More